Harrow Health Stock Technical Analysis
| HROW Stock | USD 40.94 0.99 2.36% |
As of the 1st of February, Harrow Health retains the Downside Deviation of 3.04, market risk adjusted performance of 0.0801, and Risk Adjusted Performance of 0.0409. Harrow Health technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Harrow Health variance and potential upside to decide if Harrow Health is priced fairly, providing market reflects its last-minute price of 40.94 per share. Given that Harrow Health has jensen alpha of 0.0825, we strongly advise you to confirm Harrow Health's regular market performance to make sure the company can sustain itself at a future point.
Harrow Health Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Harrow, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to HarrowHarrow Health's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Harrow Health Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 70.63 | Strong Buy | 5 | Odds |
Most Harrow analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Harrow stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Harrow Health, talking to its executives and customers, or listening to Harrow conference calls.
What growth prospects exist in Pharmaceuticals sector? Can Harrow capture new markets? Factors like these will boost the valuation of Harrow Health. Market participants price Harrow higher when confident in its future expansion prospects. Valuation analysis balances hard financial data with qualitative growth assessments. While each Harrow Health valuation metric matters, prioritizing which indicators carry greater predictive weight remains essential.
Quarterly Earnings Growth (0.64) | Earnings Share (0.13) | Revenue Per Share | Quarterly Revenue Growth 0.454 | Return On Assets |
Investors evaluate Harrow Health using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Harrow Health's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investment professionals apply varied valuation frameworks to compute inherent worth and acquire positions when market prices trade at discounts to calculated value. External factors like market trends, sector rotation, and investor psychology can cause Harrow Health's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Harrow Health's market price signifies the transaction level at which participants voluntarily complete trades.
Harrow Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Harrow Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Harrow Health.
| 11/03/2025 |
| 02/01/2026 |
If you would invest 0.00 in Harrow Health on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding Harrow Health or generate 0.0% return on investment in Harrow Health over 90 days. Harrow Health is related to or competes with Evotec SE, Tilray, Dynavax Technologies, Amphastar, BioLife Solutions, Collegium Pharmaceutical, and Kestra Medical. Harrow Health, Inc. operates as an ophthalmic-focused healthcare company More
Harrow Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Harrow Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Harrow Health upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.04 | |||
| Information Ratio | 0.0337 | |||
| Maximum Drawdown | 21.82 | |||
| Value At Risk | (4.79) | |||
| Potential Upside | 7.65 |
Harrow Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Harrow Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Harrow Health's standard deviation. In reality, there are many statistical measures that can use Harrow Health historical prices to predict the future Harrow Health's volatility.| Risk Adjusted Performance | 0.0409 | |||
| Jensen Alpha | 0.0825 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0426 | |||
| Treynor Ratio | 0.0701 |
Harrow Health February 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0409 | |||
| Market Risk Adjusted Performance | 0.0801 | |||
| Mean Deviation | 2.71 | |||
| Semi Deviation | 2.93 | |||
| Downside Deviation | 3.04 | |||
| Coefficient Of Variation | 2203.32 | |||
| Standard Deviation | 3.84 | |||
| Variance | 14.77 | |||
| Information Ratio | 0.0337 | |||
| Jensen Alpha | 0.0825 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0426 | |||
| Treynor Ratio | 0.0701 | |||
| Maximum Drawdown | 21.82 | |||
| Value At Risk | (4.79) | |||
| Potential Upside | 7.65 | |||
| Downside Variance | 9.26 | |||
| Semi Variance | 8.58 | |||
| Expected Short fall | (3.26) | |||
| Skewness | 1.02 | |||
| Kurtosis | 2.44 |
Harrow Health Backtested Returns
Harrow Health appears to be very steady, given 3 months investment horizon. Harrow Health holds Efficiency (Sharpe) Ratio of 0.0726, which attests that the entity had a 0.0726 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Harrow Health, which you can use to evaluate the volatility of the firm. Please utilize Harrow Health's Risk Adjusted Performance of 0.0409, market risk adjusted performance of 0.0801, and Downside Deviation of 3.04 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Harrow Health holds a performance score of 5. The company retains a Market Volatility (i.e., Beta) of 2.34, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Harrow Health will likely underperform. Please check Harrow Health's potential upside, as well as the relationship between the accumulation distribution and price action indicator , to make a quick decision on whether Harrow Health's current trending patterns will revert.
Auto-correlation | -0.69 |
Very good reverse predictability
Harrow Health has very good reverse predictability. Overlapping area represents the amount of predictability between Harrow Health time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Harrow Health price movement. The serial correlation of -0.69 indicates that around 69.0% of current Harrow Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.69 | |
| Spearman Rank Test | -0.61 | |
| Residual Average | 0.0 | |
| Price Variance | 12.02 |
Harrow Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Harrow Health Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Harrow Health volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Harrow Health Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Harrow Health on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Harrow Health based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Harrow Health price pattern first instead of the macroeconomic environment surrounding Harrow Health. By analyzing Harrow Health's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Harrow Health's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Harrow Health specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 6.32E-4 | 6.0E-4 | Price To Sales Ratio | 6.89 | 6.55 |
Harrow Health February 1, 2026 Technical Indicators
Most technical analysis of Harrow help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Harrow from various momentum indicators to cycle indicators. When you analyze Harrow charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0409 | |||
| Market Risk Adjusted Performance | 0.0801 | |||
| Mean Deviation | 2.71 | |||
| Semi Deviation | 2.93 | |||
| Downside Deviation | 3.04 | |||
| Coefficient Of Variation | 2203.32 | |||
| Standard Deviation | 3.84 | |||
| Variance | 14.77 | |||
| Information Ratio | 0.0337 | |||
| Jensen Alpha | 0.0825 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0426 | |||
| Treynor Ratio | 0.0701 | |||
| Maximum Drawdown | 21.82 | |||
| Value At Risk | (4.79) | |||
| Potential Upside | 7.65 | |||
| Downside Variance | 9.26 | |||
| Semi Variance | 8.58 | |||
| Expected Short fall | (3.26) | |||
| Skewness | 1.02 | |||
| Kurtosis | 2.44 |
Harrow Health February 1, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Harrow stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.04 | ||
| Daily Balance Of Power | (0.56) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 41.49 | ||
| Day Typical Price | 41.31 | ||
| Price Action Indicator | (1.05) | ||
| Market Facilitation Index | 1.76 |
Additional Tools for Harrow Stock Analysis
When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.